Monday, June 15, 2026

U.S. Hits Chinese Battery Supplier With Shocking 712% Tariff

The U.S. plans a 712% duty on Huizhou Kaixin, boosting South Korean battery firms while raising concerns over production costs.

Crash Diets Could Be Crashing Your Bones, Doctors Warn

Extreme dieting can harm bone health, increasing osteoporosis risk, especially in women. Balanced nutrition and moderate exercise are essential.

North Korea Tried an ’80s Ship Launch Trick—and It Ended in Disaster

North Korea's new destroyer capsized due to slipway issues during side-launching, highlighting risks and infrastructure challenges.

Tag: chemotherapy

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Boryung Begins First Global CDMO Supply of Alimta Through Taiwan Partnership

Boryung Pharmaceutical starts supplying Alimta to Lotus, enhancing global CDMO efforts and addressing chemotherapy drug shortages.

A New Study Suggests Selenium Could Help With One of Chemotherapy’s Most Disruptive Side Effects

A study reveals high-dose selenium can reduce exercise-related dysfunction in ovarian cancer patients undergoing chemotherapy.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

Tailored Chemotherapy Boosts Survival Rates for Elderly Colon Cancer Patients

A study reveals tailored treatment for elderly colon cancer patients boosts survival rates, challenging age-based treatment limitations.

Unlocking Triple Negative Breast Cancer: How Gene-Protein Analysis Predicts Treatment Success

A study reveals that analyzing genetic and protein data can predict chemotherapy effectiveness in triple-negative breast cancer, aiding personalized treatment.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Opdivo Wins EU Approval in Big Step for Early Lung Cancer Treatment

Opdivo gains EU approval for perioperative therapy in NSCLC, enhancing competition with Keytruda and marking a treatment paradigm shift.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.